Amylyx Pharmaceuticals (AMLX) Accumulated Expenses (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) reported Accumulated Expenses of $14.61 million for Q2 2026, down 16.4% from $17.47 million a year earlier but up 29.5% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, Amylyx Pharmaceuticals posted Accumulated Expenses of $17.91 million, down 25.2% from FY2024.
- Accumulated Expenses has a four-year compound annual growth rate of 8.3% (FY2021 to FY2025).
- By year, Accumulated Expenses came in at $23.95 million in FY2024 (-58.5%), $57.72 million in FY2023 (+50.7%), $38.31 million in FY2022 (+194.2%) and $13.02 million in FY2021.
- Five-year quarterly Accumulated Expenses spans a low of $11.28 million in Q1 2026 and a high of $67.87 million in Q1 2024.
- Year over year, Accumulated Expenses has now declined in each of the last seven quarters, with an average decline of 35.8% over the last eight quarters.
- The high point for year-over-year Accumulated Expenses in five years was Q4 2022 (growth of 194.2%); the low point was Q1 2025 (a decline of 82.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.28 million (Q1 2026), $17.91 million (Q4 2025) and $19.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Amylyx Pharmaceuticals | 3.24 Bn | 3.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.61 Mn |
| Mar 31, 2026 | 11.28 Mn |
| Dec 31, 2025 | 17.91 Mn |
| Sep 30, 2025 | 19.47 Mn |
| Jun 30, 2025 | 17.47 Mn |
| Mar 31, 2025 | 12.07 Mn |
| Dec 31, 2024 | 23.95 Mn |
| Sep 30, 2024 | 50.46 Mn |
| Jun 30, 2024 | 62.76 Mn |
| Mar 31, 2024 | 67.87 Mn |
| Dec 31, 2023 | 57.72 Mn |
| Sep 30, 2023 | 37.05 Mn |
| Jun 30, 2023 | 37.24 Mn |
| Mar 31, 2023 | 38.75 Mn |
| Dec 31, 2022 | 38.31 Mn |
| Sep 30, 2022 | 23.61 Mn |
| Jun 30, 2022 | 17.26 Mn |
| Mar 31, 2022 | 16.26 Mn |
| Dec 31, 2021 | 13.02 Mn |
API Access
Amylyx Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();